Frailty risk groups
OtherPatients older than 65 will be separated into groups of varying frailty risk
NCT Number: NCT03971851
This study will validate the utility of a novel frailty index that uses ICD diagnoses to call frailty severity in a surgical cohort of patients 65 and older
Looking for future studies?
Notify Me65 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients older than 65 will be separated into groups of varying frailty risk
Time frame: 30-days
Mortality within 30 days of surgery in each of the three frailty risk groups
Time frame: Up to 180 days
For patients surviving index hospitalization, the proportional hazard ratio of readmission between the three frailty group
Time frame: Up to 14 years
Long-term mortality of the three different frailty risk groups, compared with proportional hazard modeling
Time frame: 3 months
Incidence of patients staying more than 10-days after surgery in the three frailty risk cohorts
University of Iceland
Other
Testing and Validation of a Novel Frailty Index in a Surgical Cohort
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05346588
Anesthesia, Anesthesia Awareness
Stanford, California, United States
View Trial DetailsNCT04197271
Disease Attributes, Emergencies
Sheffield, South Yorkshire, United Kingdom
View Trial DetailsNCT03113565
Cardiac Disease, Cardiac Surgery
Neuilly-sur-Seine, Île-de-France Region, France
View Trial DetailsNCT03098524
Atelectasis, Bleeding
Neuilly-sur-Seine, Île-de-France Region, France
View Trial Details